Literature DB >> 7515353

Selective loss of [3H]kainic acid and [3H]AMPA binding in layer VI of frontal cortex in Huntington's disease.

M V Wagster1, J C Hedreen, C E Peyser, S E Folstein, C A Ross.   

Abstract

Excitatory amino acid neurotoxicity has been proposed to cause the neostriatal neuronal degeneration of Huntington's disease (HD); N-methyl-D-aspartate (NMDA), alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA), and kainate receptors have been hypothesized to play important roles in this process. We have recently reported a loss of neurons in layer VI of the cerebral cortex in HD. Using quantitative autoradiographic methods, we have now measured NMDA, AMPA, and kainate receptor binding in the frontal cerebral cortex of the brains of controls and individuals with HD. We find no change in NMDA receptor binding but a selective decrease in kainate and AMPA receptor binding in layer VI. These data suggest that cerebral cortical neurons possessing kainate or AMPA receptors may be selectively vulnerable in individuals with HD.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7515353     DOI: 10.1006/exnr.1994.1081

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  11 in total

1.  Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's disease.

Authors:  P H Reddy; V Charles; M Williams; G Miller; W O Whetsell; D A Tagle
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-06-29       Impact factor: 6.237

2.  Genotypes at the GluR6 kainate receptor locus are associated with variation in the age of onset of Huntington disease.

Authors:  D C Rubinsztein; J Leggo; M Chiano; A Dodge; G Norbury; E Rosser; D Craufurd
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

3.  Cerebral cortex structure in prodromal Huntington disease.

Authors:  Peggy C Nopoulos; Elizabeth H Aylward; Christopher A Ross; Hans J Johnson; Vincent A Magnotta; Andrew R Juhl; Ronald K Pierson; James Mills; Douglas R Langbehn; Jane S Paulsen
Journal:  Neurobiol Dis       Date:  2010-08-02       Impact factor: 5.996

4.  Longitudinal change in regional brain volumes in prodromal Huntington disease.

Authors:  Elizabeth H Aylward; Peggy C Nopoulos; Christopher A Ross; Douglas R Langbehn; Ronald K Pierson; James A Mills; Hans J Johnson; Vincent A Magnotta; Andrew R Juhl; Jane S Paulsen
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-09-30       Impact factor: 10.154

Review 5.  Dopamine and glutamate in Huntington's disease: A balancing act.

Authors:  Véronique M André; Carlos Cepeda; Michael S Levine
Journal:  CNS Neurosci Ther       Date:  2010-04-08       Impact factor: 5.243

6.  fMRI biomarker of early neuronal dysfunction in presymptomatic Huntington's Disease.

Authors:  Jane S Paulsen; Janice L Zimbelman; Sean C Hinton; Douglas R Langbehn; Catherine L Leveroni; Michelle L Benjamin; Norman C Reynolds; Stephen M Rao
Journal:  AJNR Am J Neuroradiol       Date:  2004 Nov-Dec       Impact factor: 3.825

7.  Disruption of Rab11 activity in a knock-in mouse model of Huntington's disease.

Authors:  Xueyi Li; Ellen Sapp; Kathryn Chase; Laryssa A Comer-Tierney; Nicholas Masso; Jonathan Alexander; Patrick Reeves; Kimberly B Kegel; Antonio Valencia; Miguel Esteves; Neil Aronin; Marian Difiglia
Journal:  Neurobiol Dis       Date:  2009-08-20       Impact factor: 5.996

Review 8.  Ionotropic glutamate receptors & CNS disorders.

Authors:  Derek Bowie
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-04       Impact factor: 4.388

Review 9.  Therapeutic potential of kainate receptors.

Authors:  Carlos Matute
Journal:  CNS Neurosci Ther       Date:  2010-12-06       Impact factor: 5.243

10.  Loss-of-Function Mutations in FRRS1L Lead to an Epileptic-Dyskinetic Encephalopathy.

Authors:  Marianna Madeo; Michelle Stewart; Yuyang Sun; Nadia Sahir; Sarah Wiethoff; Indra Chandrasekar; Anna Yarrow; Jill A Rosenfeld; Yaping Yang; Dawn Cordeiro; Elizabeth M McCormick; Colleen C Muraresku; Tyler N Jepperson; Lauren J McBeth; Mohammed Zain Seidahmed; Heba Y El Khashab; Muddathir Hamad; Hamid Azzedine; Karl Clark; Silvia Corrochano; Sara Wells; Mariet W Elting; Marjan M Weiss; Sabrina Burn; Angela Myers; Megan Landsverk; Patricia L Crotwell; Quinten Waisfisz; Nicole I Wolf; Patrick M Nolan; Sergio Padilla-Lopez; Henry Houlden; Richard Lifton; Shrikant Mane; Brij B Singh; Marni J Falk; Saadet Mercimek-Mahmutoglu; Kaya Bilguvar; Mustafa A Salih; Abraham Acevedo-Arozena; Michael C Kruer
Journal:  Am J Hum Genet       Date:  2016-05-26       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.